Lv1
10 积分 2022-12-20 加入
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
27天前
已完结
Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases
27天前
已完结
CAR-T/NK/M-based combination therapies in cancer: A comprehensive review
27天前
已完结
To be or not to be NKT: Natural killer T cells in the liver
1个月前
已完结
Engineering CAR T cells to secrete VEGF-neutralizing scFvs enhances antitumor activity against solid tumors
2个月前
已完结
Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
3个月前
已完结
Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
3个月前
已完结
VEGF signaling in cancer treatment
3个月前
已完结
Hallmarks of cancer-Then and now, and beyond
3个月前
已完结
Application of adoptive cell therapy in hepatocellular carcinoma
4个月前
已完结
皖公网安备34019202002308
